Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chromium gluconate is a chemical compound consisting of trivalent chromium and gluconic acid. It is used as a dietary supplement to provide the essential trace mineral chromium, which plays a role in normal glucose metabolism and peripheral nerve function. Chromium acts as part of the glucose tolerance factor, enhancing insulin sensitivity by increasing insulin binding to cells, raising insulin receptor density, and activating insulin receptor kinase. This leads to improved cellular response to insulin. Chromium supplementation may help normalize blood glucose levels in individuals with deficiency but has limited evidence for benefit in healthy individuals or those with well-controlled diabetes[1][2][4]. The compound is not associated with any specific pharmaceutical developer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chromium gluconate.